Estée Lauder bets on 111Skin

The American group has announced that it has taken a minority stake in the luxury skincare brand, without disclosing the amount.

Founded in 2012 by aesthetic surgeon Yannis Alexandrides, 111Skin builds on its NAC Y2  technology – designed to support skin repair – and on clinical expertise to offer more than 30 premium products, priced at up to $1,000. Positioned within the fast-growing ʺtreatment-inspiredʺ skincare segment, the brand is distributed through selective retail channels and online.

With this investment, The Estée Lauder Companies aims to strengthen its positioning in scientific innovation and support the international expansion of 111SKIN, which is already well established in North America, Europe and Asia. The founder will remain involved in the brand’s development alongside his management team, as the partnership seeks to accelerate its global growth.